Are Ramsay Health Care Limited’s (ASX:RHC) Returns Worth Your While?

In this article:

Today we are going to look at Ramsay Health Care Limited (ASX:RHC) to see whether it might be an attractive investment prospect. In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business.

First up, we'll look at what ROCE is and how we calculate it. Second, we'll look at its ROCE compared to similar companies. Last but not least, we'll look at what impact its current liabilities have on its ROCE.

Understanding Return On Capital Employed (ROCE)

ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business. Generally speaking a higher ROCE is better. Overall, it is a valuable metric that has its flaws. Renowned investment researcher Michael Mauboussin has suggested that a high ROCE can indicate that 'one dollar invested in the company generates value of more than one dollar'.

How Do You Calculate Return On Capital Employed?

The formula for calculating the return on capital employed is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for Ramsay Health Care:

0.11 = AU$1.1b ÷ (AU$13b - AU$2.7b) (Based on the trailing twelve months to June 2019.)

So, Ramsay Health Care has an ROCE of 11%.

See our latest analysis for Ramsay Health Care

Does Ramsay Health Care Have A Good ROCE?

ROCE is commonly used for comparing the performance of similar businesses. It appears that Ramsay Health Care's ROCE is fairly close to the Healthcare industry average of 10.0%. Separate from Ramsay Health Care's performance relative to its industry, its ROCE in absolute terms looks satisfactory, and it may be worth researching in more depth.

The image below shows how Ramsay Health Care's ROCE compares to its industry, and you can click it to see more detail on its past growth.

ASX:RHC Past Revenue and Net Income, January 3rd 2020
ASX:RHC Past Revenue and Net Income, January 3rd 2020

When considering ROCE, bear in mind that it reflects the past and does not necessarily predict the future. Companies in cyclical industries can be difficult to understand using ROCE, as returns typically look high during boom times, and low during busts. ROCE is only a point-in-time measure. Future performance is what matters, and you can see analyst predictions in our free report on analyst forecasts for the company.

Do Ramsay Health Care's Current Liabilities Skew Its ROCE?

Current liabilities are short term bills and invoices that need to be paid in 12 months or less. Due to the way the ROCE equation works, having large bills due in the near term can make it look as though a company has less capital employed, and thus a higher ROCE than usual. To check the impact of this, we calculate if a company has high current liabilities relative to its total assets.

Ramsay Health Care has total assets of AU$13b and current liabilities of AU$2.7b. As a result, its current liabilities are equal to approximately 21% of its total assets. Current liabilities are minimal, limiting the impact on ROCE.

Our Take On Ramsay Health Care's ROCE

With that in mind, Ramsay Health Care's ROCE appears pretty good. There might be better investments than Ramsay Health Care out there, but you will have to work hard to find them . These promising businesses with rapidly growing earnings might be right up your alley.

I will like Ramsay Health Care better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

Advertisement